Ashland Sees Adj. EBITDA Pressure In Q3, Backs FY21 View - Quick Facts

Ashland Global Holdings Inc. (ASH), a premier specialty materials company, Thursday said it continues to expect to report fiscal; 2021 adjusted EBITDA of $570 million to $590 million.

The company said it expects approximately $5 million to $10 million of adjusted EBITDA pressure in the fiscal third quarter as supply-chain constraints continue to be a challenge. However, these factors would stabilize in the fourth quarter.

Ashland noted that economic recovery in the U.S. and other regions is driving strong demand for most products in the company's Life Sciences, Personal Care and Household and Specialty Additives end markets.

Meanwhile, availability of some raw materials in addition to shipping, logistics and packaging challenges are offsetting the demand. In addition, supply-chain inefficiencies are resulting in higher overall cost.

Guillermo Novo, chairman and chief executive officer, Ashland, said, "We are encouraged by the improving demand in each of our segments."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT